apollo
0
Written By Santoshini Reddy G , M Pharmacy
Reviewed By Dr Aneela Siddabathuni , MPharma., PhD
Last Updated Nov 10, 2024 | 7:16 PM IST
SGLTR-M Tablet is an anti-diabetic medicine used in the treatment of Type II diabetes. This combination medicine works by increasing the amount of insulin generated by the pancreas and helps remove excess sugar from the body via urine. This medicine may cause common side effects like stomach upset, hypoglycaemia, headache, nausea, and vomiting.
Read more
75 people bought
in last 30 days
Prescription drug

Whats That

tooltip
Prescription drug
 Trailing icon
Consult Doctor

Manufacturer/Marketer

Mankind Pharma Pvt Ltd

Consume Type

ORAL

Return Policy

Not Returnable

Expires on or after

Jan-27

for this medicine

About SGLTR-M Tablet

SGLTR-M Tablet belongs to the group of anti-diabetic medicines used to treat type-2 diabetes mellitus adjunct to diet and exercise. Type-2 diabetes mellitus is also known as non-insulin-dependent diabetes or adult-onset diabetes. It is a medical condition in which blood glucose levels are above normal due to insulin deficiency, insulin resistance, or both.
 
SGLTR-M Tablet is a combination of two drugs, namely: Remogliflozin etabonate and Metformin hydrochloride. Remogliflozin etabonate helps in removing excess sugar from the body via urine. Metformin hydrochloride works by reducing the sugar production by cells in the liver and delays sugar absorption from the intestines. Also, it increases the body's sensitivity to insulin. Together, SGLTR-M Tablet helps control blood sugar levels.
 
You are advised to take SGLTR-M Tablet for as long as your doctor has prescribed it for you, depending on your medical condition. In some cases, you may experience certain common side effects such as stomach upset, hypoglycaemia, nausea, and vomiting. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to consult your doctor if the side effects persist or worsen.
 
Consult your doctor if you are pregnant or breastfeeding. Avoid alcohol consumption while taking SGLTR-M Tablet as it might cause unpleasant side-effects. Limited information is available regarding the usage of SGLTR-M Tablet in children, so please consult a doctor if you have any concerns. Inform your doctor about all the medicines you are taking and your health condition to rule out any unpleasant side effects/interactions.

Uses of SGLTR-M Tablet

Treatment of Type-2 diabetes mellitus

Medicinal Benefits

SGLTR-M Tablet is a combination of two anti-diabetic drugs, namely: Remogliflozin etabonate and Metformin hydrochloride. SGLTR-M Tablet is used to treat type-2 diabetes mellitus. Remogliflozin etabonate helps in removing excess sugar from the body via urine. Metformin hydrochloride reduces sugar production by cells in the liver and delays sugar absorption from the intestines. Also, it increases the body's sensitivity to insulin. Together, SGLTR-M Tablet helps control blood sugar levels.

Directions for Use

Take SGLTR-M Tablet with or after food. Swallow SGLTR-M Tablet as a whole with a glass of water; do not break, chew or crush it.

Storage

Store in a cool and dry place away from sunlight

Side Effects of SGLTR-M Tablet

  • Stomach upset
  • Hypoglycaemia (low blood sugar levels)
  • Nausea
  • Vomiting

Drug Warnings

Do not take SGLTR-M Tablet if you are allergic to any of its contents. Inform your doctor if you have heart problems, diabetic ketoacidosis, skin problems, acute pancreatitis, low blood sugar levels, kidney or liver problems. Consult your doctor if you are pregnant or breastfeeding. Avoid alcohol consumption while taking SGLTR-M Tablet as it might cause unpleasant side-effects. Inform your doctor about all the medicines you are taking and your health condition to rule out any unpleasant side effects. 

Drug Interactions

Drug-Drug Interactions: SGLTR-M Tablet may interact with anti-diabetic medicines (insulin glargine), diuretics (furosemide), and hormones (levothyroxine).

Drug-Food Interactions: No interactions found/established. 

Drug-Disease Interactions: Inform your doctor if you have diabetic ketoacidosis, dialysis, skin disorder, acute pancreatitis, or hypoglycaemia (low blood sugar levels).

Drug-Drug Interactions Checker List

  • INSULIN GLARGINE
  • FUROSEMIDE
  • LEVOTHYROXINE

Habit Forming

No

Diet & Lifestyle Advise

  • Include foods rich in healthy carbohydrates and fibre, fruits, whole grains, and vegetables.
  • Try eating food at regular intervals. Do not skip meals. Also, try not to overeat.
  • Follow a healthy diet and walk for at least 45 minutes to complement treatment with SGLTR-M Tablet .
  • Maintain a healthy weight by exercising regularly.
  • Rest properly, avoid stress by doing meditation or yoga.

Special Advise

  • Regularly monitor blood glucose levels while taking SGLTR-M Tablet .
  • Try not to skip any doses and take SGLTR-M Tablet for as long as your doctor has prescribed it for you.
  • Always carry sugary food such as candy or fruit juice and consume them if you experience hypoglycaemia.
  • Consult a doctor if you notice sores or signs of infections. 

Disease/Condition Glossary

Type-2 diabetes mellitus: It is also known as non-insulin-dependent diabetes. It is a chronic or lifelong disease that keeps the body from utilizing insulin properly. Diabetes is a medical condition in which blood glucose levels are above normal. People with type 2 diabetes either do not produce enough insulin, or the insulin produced cannot perform its function in the body (insulin resistance). Middle-aged or older individuals are most likely to suffer from type 2 diabetes; hence it is also known as adult-onset diabetes. Type 2 diabetes symptoms include lack of energy, tiredness, frequent urination, excess thirst, dry mouth, blurry vision, constant hunger, and weight loss.

bannner image

Alcohol

Caution

You are recommended to avoid alcohol consumption while taking SGLTR-M Tablet to prevent unpleasant side effects.

bannner image

Pregnancy

Caution

Please consult your doctor if you have any concerns regarding this; your doctor will prescribe only if the benefits outweigh the risks.

bannner image

Breast Feeding

Caution

Please consult your doctor if you have any concerns regarding this; your doctor will decide whether SGLTR-M Tablet can be given to breastfeeding mothers or not.

bannner image

Driving

Caution

It is not known if SGLTR-M Tablet affects your ability to drive. Drive or operate machinery only if you are alert.

bannner image

Liver

Caution

Dose adjustment may be needed. Please consult your doctor if you have a liver impairment or any concerns regarding this.

bannner image

Kidney

Caution

Dose adjustment may be needed. Please consult your doctor if you have kidney impairment or any concerns regarding this.

bannner image

Children

Caution

Limited information is available regarding the usage of SGLTR-M Tablet in children, so please consult a doctor.

Country of origin

India

Manufacturer/Marketer address

208, Okhla Industrial Estate, Phase III, New Delhi - 110020
Other Info - SGL0002

Author Details

Doctor imageWe provide you with authentic, trustworthy and relevant information

FAQs

SGLTR-M Tablet belongs to the group of anti-diabetic medicines used to treat type-2 diabetes mellitus adjunct to diet and exercise.
SGLTR-M Tablet contains Remogliflozin etabonate and Metformin hydrochloride. Remogliflozin etabonate helps in removing excess sugar from the body via urine. Metformin hydrochloride reduces sugar production by cells in the liver and delays sugar absorption from the intestines. Also, it increases the body's sensitivity to insulin. Together, SGLTR-M Tablet helps control blood sugar levels.
Do not stop taking SGLTR-M Tablet without consulting your doctor, as it may cause an increase in blood glucose levels. Continue taking SGLTR-M Tablet for as long as your doctor has prescribed it to you. Do not be reluctant to speak with your doctor if you experience any difficulty while taking SGLTR-M Tablet .
Hypoglycaemia/low blood sugar levels could be the side effect of SGLTR-M Tablet . Hypoglycaemia generally occurs when SGLTR-M Tablet is taken along with other antidiabetic medicines, without food or with alcohol. Consume sugary food such as candy or fruit juice if you experience hypoglycaemic symptoms such as dizziness, cold sweats, anxiety, or tremor. Regularly monitor blood glucose levels while taking SGLTR-M Tablet .
If you miss a dose, try to take it as soon as you remember. However, if it is almost time for the scheduled dose, skip the missed dose and take the scheduled dose instead. Avoid taking a double dose as it might cause unpleasant side effects or overdose.
Low-fibre/high-fat diet, sugary diet, obesity, smoking, stress, lack of exercise, age, genetic factors, and certain medical conditions are the common causes of diabetes.
The common side effects of SGLTR-M Tablet are stomach upset, hypoglycaemia (low blood sugar levels), nausea and vomiting). If these side effects persist or worsen, please consult your doctor.

Disclaimer

While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.

Recommended for a 30-day course: 3 Strips

Add 3 Strips